Safer, Daniel J.

A three-country comparison of psychotropic medication prevalence in youth

Zito, J. M., Safer, D. J., Berg, L. T. D. J.-V. D., Janhsen, K., Fegert, J. M., Gardner, J. F., Glaeske, G., & Valluri, S. C. (2008) · Child and Adolescent Psychiatry and Mental Health

Mental Health Treatment and AccessChild and Adolescent Psychosocial and Emotional Development

Cited by 201

DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS

SAFER, D. J. (2002) · The Journal of Nervous and Mental Disease

Pharmaceutical industry and healthcareStatistical Methods in Clinical Trials

Cited by 180

Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder

Zito, J. M., Safer, D. J., dosReis, S., Magder, L. S., Gardner, J. F., & Zarin, D. A. (1999) · Archives of Pediatrics & Adolescent Medicine

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 162

Growth rebound after termination of stimulant drugs

Safer, D. J., Allen, R. P., & Barr, E. (1975) · The Journal of Pediatrics

Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment

Cited by 123

Recent Child Pharmacoepidemiological Findings

Zito, J. M., & Safer, D. J. (2005) · Journal of Child and Adolescent Psychopharmacology

Pharmaceutical studies and practicesAttention Deficit Hyperactivity Disorder

Cited by 33

Raising the Minimum Effective Dose of Serotonin Reuptake Inhibitor Antidepressants: Adverse Drug Events

Safer, D. J. (2016) · Journal of Clinical Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 19